Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BL.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BL.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BL.2ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
BE.7ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
BE.7ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
BE.7ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BE.7ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
BE.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BE.7NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BE.7NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BE.7ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-14094.8Japan
BA.5.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.5.1ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
BA.5.2.20ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
BA.5.2.20ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
BA.5.2.20ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BA.5.2.20ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BA.5.2.20SYoung-STATACATGTCTCTGGGACCA20452176321782F29.6049Singapore
BA.5.2.20NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BA.5.2.20NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.5.2.20ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
BQ.1.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
BQ.1.1ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-3635.26China
BQ.1.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-301.668South Korea
BQ.1.1ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
BQ.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-3680.15Singapore
BQ.1.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BQ.1.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BQ.1.1ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
DV.3ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
DV.3ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
DV.3ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-301.668South Korea
DV.3ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
DV.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
DV.3NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
DV.3NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
DV.3ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
BA.4.1.8ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-19262.2China
BA.4.1.8ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-3635.26China
BA.4.1.8ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-301.668South Korea
BA.4.1.8ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
BA.4.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.4.1.8NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BA.4.1.8NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.4.1.8ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-2648.21Japan
BN.1.3ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
BN.1.3ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
BN.1.3ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-301.668South Korea
BN.1.3ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-4768.1Hong Kong
BN.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used